$LUCD
Lucid Diagnostics Inc Stock $lucd

$lucd Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000149315224018800 Filed on May 13, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue	$1.000M	$1.000M	$446.0K
YoY Change	528.93%	124.22%	135.98%
Cost Of Revenue	$1.614M	$1.656M	$1.338M
YoY Change	4.2%	23.77%	262.6%
Gross Profit	-$638.0K	-$655.0K	-$892.0K
YoY Change	-54.1%	-26.57%	395.56%
Gross Profit Margin	-63.8%	-65.5%	-200.0%
Selling, General & Admin	$9.077M	$8.264M	$10.64M
YoY Change	15.45%	-22.32%	15.52%
% of Gross Profit
Research & Development	$1.372M	$1.501M	$2.282M
YoY Change	-24.9%	-34.22%	-20.79%
% of Gross Profit
Depreciation & Amortization	$229.0K	$501.0K	$612.0K
YoY Change	-63.82%	-18.14%	2450.0%
% of Gross Profit
Operating Expenses	$12.17M	$11.79M	$14.76M
YoY Change	3.62%	-20.12%	22.11%
Operating Profit	-$11.19M	-$10.79M	-$14.32M
YoY Change	-3.38%	-24.62%	16.68%
Interest Expense	$6.000K	$12.00K	$33.00K
YoY Change	-97.31%	-63.64%
% of Operating Profit
Other Income/Expense, Net	$187.0K	$180.0K	-$1.930M
YoY Change	-7.88%	-109.33%	-193100.0%
Pretax Income	-$11.01M	-$10.61M	-$16.25M
YoY Change	-3.3%	-34.68%	32.41%
Income Tax
% Of Pretax Income
Net Earnings	-$11.01M	-$10.61M	-$16.25M
YoY Change	-3.3%	-34.68%	32.41%
Net Earnings / Revenue	-1100.5%	-1061.2%	-3642.83%
Basic Earnings Per Share	-$0.23	-$0.40	-$0.40
Diluted Earnings Per Share	-$0.23	-$0.40	-$0.40
COMMON SHARES
Basic Shares Outstanding	52.11M shares	48.24M shares	43.39M shares
Diluted Shares Outstanding	48.21M shares	45.01M shares	40.97M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$24.92M	$24.77M	$39.52M
YoY Change	-23.49%	-37.33%	-17.52%
Cash & Equivalents	$24.92M	$24.77M	$39.52M
Short-Term Investments
Other Short-Term Assets	$2.184M	$2.355M	$2.172M
YoY Change	-30.53%	8.43%	-49.77%
Inventory	$683.0K	$410.0K
Prepaid Expenses
Receivables	$160.0K	$49.00K	$27.00K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$27.95M	$27.58M	$41.72M
YoY Change	-21.82%	-33.89%	-20.28%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.050M	$1.242M	$1.502M
YoY Change	-24.41%	-17.31%	-54.75%
Goodwill
YoY Change
Intangibles	$947.0K	$1.052M	$2.940M
YoY Change	-61.11%	-64.22%
Long-Term Investments
YoY Change
Other Assets	$1.132M	$1.132M	$1.078M
YoY Change	5.01%	5.01%	55.11%
Total Long-Term Assets	$6.166M	$4.465M	$7.404M
YoY Change	-8.48%	-39.69%	-23.89%
TOTAL ASSETS
Total Short-Term Assets	$27.95M	$27.58M	$41.72M
Total Long-Term Assets	$6.166M	$4.465M	$7.404M
Total Assets	$34.11M	$32.05M	$49.13M
YoY Change	-19.71%	-34.76%	-20.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$903.0K	$969.0K	$625.0K
YoY Change	41.76%	55.04%	-85.99%
Accrued Expenses	$3.611M	$3.997M	$3.241M
YoY Change	-3.42%	23.33%	8.21%
Deferred Revenue
YoY Change
Short-Term Debt	$11.47M	$15.01M	$19.53M
YoY Change	-48.6%	-23.13%	1003.22%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$15.98M	$19.98M	$23.39M
YoY Change	-40.11%	-14.6%	65.74%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$2.154M	$177.0K	$826.0K
YoY Change	194.26%	-78.57%	-43.23%
Total Long-Term Liabilities	$2.154M	$177.0K	$826.0K
YoY Change	194.26%	-78.57%	-43.23%
TOTAL LIABILITIES
Total Short-Term Liabilities	$15.98M	$19.98M	$23.39M
Total Long-Term Liabilities	$2.154M	$177.0K	$826.0K
Total Liabilities	$18.13M	$20.15M	$24.22M
YoY Change	-33.85%	-16.78%	55.56%
SHAREHOLDERS EQUITY
Retained Earnings	-$179.9M	-$168.8M	-$114.3M
YoY Change	43.08%	47.7%
Common Stock	$49.00K	$47.00K	$42.00K
YoY Change	16.67%	11.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$15.98M	$11.89M	$24.91M
YoY Change
Total Liabilities & Shareholders Equity	$34.11M	$32.05M	$49.13M
YoY Change	-19.71%	-34.76%	-20.84%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$11.01M	-$10.61M	-$16.25M
YoY Change	-3.3%	-34.68%	32.41%
Depreciation, Depletion And Amortization	$229.0K	$501.0K	$612.0K
YoY Change	-63.82%	-18.14%	2450.0%
Cash From Operating Activities	-$11.48M	-$12.60M	-$7.045M
YoY Change	63.75%	78.85%	21.97%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$37.00K	$17.00K
YoY Change	-100.0%	117.65%	-111.49%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00	-$37.00K	-$17.00K
YoY Change	-100.0%	117.65%	-88.51%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	11.63M	$18.52M	$24.11M
YoY Change	15410.67%	-23.18%	12793.05%
NET CHANGE
Cash From Operating Activities	-11.48M	-$12.60M	-$7.045M
Cash From Investing Activities	0.000	-$37.00K	-$17.00K
Cash From Financing Activities	11.63M	$18.52M	$24.11M
Net Change In Cash	151.0K	$5.873M	$17.05M
YoY Change	-102.17%	-65.55%	-397.16%
FREE CASH FLOW
Cash From Operating Activities	-$11.48M	-$12.60M	-$7.045M
Capital Expenditures	$0.00	$37.00K	$17.00K
Free Cash Flow	-$11.48M	-$12.64M	-$7.062M
YoY Change	63.4%	78.94%	25.48%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	LUCD	Share Based Compensation Of Parent ShareBasedCompensationOfParent	189000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-176000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-704000	usd
CY2024Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-2793000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12612000	usd
CY2024Q1	LUCD	Payments Of Purchase Of Equipment PaymentsOfPurchaseOfEquipment	37000	usd
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	49044502	shares
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	LUCD	Loss On Issue And Offering Costs Senior Secured Convertible Note LossOnIssueAndOfferingCostsSeniorSecuredConvertibleNote		usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments		usd
CY2024Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2024Q1	LUCD	Loss On Issue Senior Secured Convertible Note LossOnIssueSeniorSecuredConvertibleNote		usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2024Q1	LUCD	Issue Common Stock Settle Termination Payment IssueCommonStockSettleTerminationPayment		usd
CY2023Q1	LUCD	Operating Expenses Settled With Issuance Of Common Stock OperatingExpensesSettledWithIssuanceOfCommonStock		usd
CY2024Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2024Q1	LUCD	Proceeds Issuance Of Common Stock At The Market Facility ProceedsIssuanceOfCommonStockAtTheMarketFacility		usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
CY2023Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments		usd
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	001-40901
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	LUCID DIAGNOSTICS INC.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	82-5488042
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	360 Madison Avenue
CY2024Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	25th Floor
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10017
CY2024Q1	dei	City Area Code CityAreaCode	(917)
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	813-1828
CY2024Q1	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value per share
CY2024Q1	dei	Trading Symbol TradingSymbol	LUCD
CY2024Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24769000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18896000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	49000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	45000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	410000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	278000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2355000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2854000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	27583000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	22073000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1242000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1334000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1039000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1307000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1052000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1424000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1132000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1132000	usd
CY2024Q1	us-gaap	Assets Assets	32048000	usd
CY2023Q4	us-gaap	Assets Assets	27270000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	969000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1146000	usd
CY2024Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	3136000	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	3841000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	861000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1106000	usd
CY2024Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	13140000	usd
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	13950000	usd
CY2024Q1	LUCD	Due To Parent Msa Fee And Operating Expenses DueToParentMSAFeeAndOperatingExpenses	1871000	usd
CY2023Q4	LUCD	Due To Parent Msa Fee And Operating Expenses DueToParentMSAFeeAndOperatingExpenses	9339000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	19977000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	29382000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	177000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	199000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	20154000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	29581000	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue	44285000	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	18625000	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	46747062	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	46747062	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	42329864	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	42329864	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	47000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	42000	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	136411000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	129763000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-168849000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-150741000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	11894000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-2311000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	32048000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	27270000	usd
CY2024Q1	us-gaap	Revenues Revenues	1001000	usd
CY2023Q1	us-gaap	Revenues Revenues	446000	usd
CY2024Q1	LUCD	Operating Cost Of Revenue OperatingCostOfRevenue	1656000	usd
CY2023Q1	LUCD	Operating Cost Of Revenue OperatingCostOfRevenue	1338000	usd
CY2024Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4194000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4127000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4070000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6900000	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	372000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	505000	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1501000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1893000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	11793000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	14763000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-10792000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-14317000	usd
CY2024Q1	us-gaap	Interest Income Other InterestIncomeOther	68000	usd
CY2023Q1	us-gaap	Interest Income Other InterestIncomeOther	78000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	12000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	33000	usd
CY2024Q1	LUCD	Change In Fair Value Senior Secured Convertible Note ChangeInFairValueSeniorSecuredConvertibleNote	-291000	usd
CY2023Q1	LUCD	Change In Fair Value Senior Secured Convertible Note ChangeInFairValueSeniorSecuredConvertibleNote	789000	usd
CY2023Q1	LUCD	Loss On Issue And Offering Costs Senior Secured Convertible Note LossOnIssueAndOfferingCostsSeniorSecuredConvertibleNote	1186000	usd
CY2024Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-167000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	180000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1930000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10612000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16247000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-10612000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-16247000	usd
CY2024Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	7496000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-18108000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-16247000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.40
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.40
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.40
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.40
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	45014410	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	45014410	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40970504	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40970504	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-2311000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	4000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	744000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	189000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	688000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	353000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	5670000	usd
CY2024Q1	LUCD	Stock Issued During Period Value New Exchange Series And Series A1 Preferred Stock StockIssuedDuringPeriodValueNewExchangeSeriesAndSeriesA1PreferredStock	-31791000	usd
CY2024Q1	LUCD	Stock Issued During Period Value New Issuance Series B Preferred Stock StockIssuedDuringPeriodValueNewIssuanceSeriesBPreferredStock	44285000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	4675000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-10612000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	11894000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	23047000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	23047000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2817000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	391000	usd
CY2023Q1	LUCD	Stock Issued During Period Value Asset Acquisitions Termination Payment StockIssuedDuringPeriodValueAssetAcquisitionsTerminationPayment	713000	usd
CY2023Q1	LUCD	Stock Issued During Period Value At The Market Facility Net Of Deferred Financing Charges StockIssuedDuringPeriodValueAtTheMarketFacilityNetOfDeferredFinancingCharges	284000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	276000	usd
CY2023Q1	LUCD	Stock Issued During Period Value New Issuance Series A Preferred Stock StockIssuedDuringPeriodValueNewIssuanceSeriesAPreferredStock	13625000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-16247000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	24906000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	24906000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-10612000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-16247000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	501000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	612000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	743000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2817000	usd
CY2023Q1	LUCD	Share Based Compensation Of Parent ShareBasedCompensationOfParent	391000	usd
CY2024Q1	LUCD	Change In Fair Value Senior Secured Convertible Note ChangeInFairValueSeniorSecuredConvertibleNote	-291000	usd
CY2023Q1	LUCD	Change In Fair Value Senior Secured Convertible Note ChangeInFairValueSeniorSecuredConvertibleNote	789000	usd
CY2023Q1	LUCD	Loss On Issue Senior Secured Convertible Note LossOnIssueSeniorSecuredConvertibleNote	1111000	usd
CY2024Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-167000	usd
CY2023Q1	LUCD	Issue Common Stock Settle Termination Payment IssueCommonStockSettleTerminationPayment	713000	usd
CY2024Q1	LUCD	Operating Expenses Settled With Issuance Of Common Stock OperatingExpensesSettledWithIssuanceOfCommonStock	23000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	10000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-345000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	275000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-431000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	743000	usd
CY2023Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	2667000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7120000	usd
CY2023Q1	LUCD	Payments Of Purchase Of Equipment PaymentsOfPurchaseOfEquipment	17000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-37000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-17000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	18165000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	13625000	usd
CY2023Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	10000000	usd
CY2023Q1	LUCD	Proceeds Issuance Of Common Stock At The Market Facility ProceedsIssuanceOfCommonStockAtTheMarketFacility	284000	usd
CY2024Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4000	usd
CY2024Q1	LUCD	Proceeds From Issuance Of Common Stock One ProceedsFromIssuanceOfCommonStockOne	353000	usd
CY2023Q1	LUCD	Proceeds From Issuance Of Common Stock One ProceedsFromIssuanceOfCommonStockOne	276000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	18522000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	24185000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	5873000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	17048000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	18896000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	22474000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	24769000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	39522000	usd
CY2024Q1	us-gaap	Revenues Revenues	1000000.0	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-18100000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12600000	usd
CY2024Q1	LUCD	Working Capital WorkingCapital	7600000	usd
CY2024Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	13100000	usd
CY2024Q1	us-gaap	Cash Cash	24800000	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_842_eus-gaap--UseOfEstimates_zzJXjOkzQSId" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zcISmcKsRjE6">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In preparing the unaudited condensed consolidated financial statements in conformity with U.S. GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and the determination of corresponding carrying value reserves, if any, and liabilities and the disclosure of contingent losses, as of the date of the unaudited condensed consolidated financial statements, as well as the reported amounts of revenue and expenses during the reporting period. Significant estimates in these unaudited condensed consolidated financial statements include those related to the estimated fair value of debt obligations, stock-based equity awards and intangible assets. Other significant estimates include the estimated incremental borrowing rate, the provision or benefit for income taxes and the corresponding valuation allowance on deferred tax assets. Additionally, management’s assessment of the Company’s ability to continue as a going concern involves the estimation of the amount and timing of future cash inflows and outflows. On an ongoing basis, the Company evaluates its estimates and assumptions. The Company bases its estimates on historical experience and on various other assumptions believed to be reasonable. Due to inherent uncertainty involved in making estimates, actual results reported in future periods may be affected by changes in these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Security Deposit SecurityDeposit	1732000	usd
CY2023Q4	us-gaap	Security Deposit SecurityDeposit	1981000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2355000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2854000	usd
CY2024Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_841_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zQ5YAlWg7bO4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_z9VDq8lKH7y9">Reclassifications</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain prior-year amounts have been reclassified to conform to the current year presentation, which includes presenting costs of revenue within operating expenses on the statements of operations, in the unaudited condensed consolidated financial statements and accompanying notes to the unaudited condensed consolidated financial statements. The impact of the reclassifications made to prior year amounts is not material and did not affect net loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1001000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	446000	usd
CY2024Q1	LUCD	Operating Cost Of Revenue OperatingCostOfRevenue	1656000	usd
CY2023Q1	LUCD	Operating Cost Of Revenue OperatingCostOfRevenue	1338000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	9339000	usd
CY2024Q1	us-gaap	Management Fee Expense ManagementFeeExpense	2500000	usd
CY2024Q1	LUCD	Employee Retention Credit Benefits EmployeeRetentionCreditBenefits	455000	usd
CY2024Q1	LUCD	On Behalf Of Obo Activities OnBehalfOfOBOActivities	159000	usd
CY2024Q1	LUCD	Cash Payments CashPayments	-5907000	usd
CY2024Q1	LUCD	Payment To Related Parties PaymentToRelatedParties	-4675000	usd
CY2024Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1871000	usd
CY2024Q1	LUCD	Prepaid Service Providers And Suppliers PrepaidServiceProvidersAndSuppliers	228000	usd
CY2023Q4	LUCD	Prepaid Service Providers And Suppliers PrepaidServiceProvidersAndSuppliers	266000	usd
CY2024Q1	us-gaap	Prepaid Insurance PrepaidInsurance	395000	usd
CY2023Q4	us-gaap	Prepaid Insurance PrepaidInsurance	607000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	855000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	133000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	69000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	30000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1088000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	50000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1038000	usd
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	305000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	285000	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	22000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	125000	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y3M10D
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y9M7D
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.07875	pure
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.07875	pure
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1039000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1307000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1038000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1305000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	861000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1106000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	177000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	199000	usd
CY2024Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	3333	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.31
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	168337	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.57
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	5305000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	5305000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	4253000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3881000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1052000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1424000	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	372000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	505000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	316000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	421000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	315000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1052000	usd
CY2024Q1	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	13140000	usd
CY2023Q4	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	13950000	usd
CY2024Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	10936000	usd
CY2024Q1	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	13140000	usd
CY2023Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	11019000	usd
CY2023Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	13950000	usd
CY2023Q1	us-gaap	Debt Conversion Original Debt Interest Rate Of Debt DebtConversionOriginalDebtInterestRateOfDebt	0.825	pure
CY2023Q1	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.30
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5504383	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.00
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y6M
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	765000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3000000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.25
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8332713	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.74
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y9M18D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	195000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	2655413	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	2.29
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P7Y7M6D
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	195000	usd
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	933000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3208000	usd
CY2024Q1	LUCD	Fair Value Of Series B Preferred Stock Issued Shares FairValueOfSeriesBPreferredStockIssuedShares	44285000	shares
CY2024Q1	LUCD	Fair Value Of Series B Preferred Stock Issued FairValueOfSeriesBPreferredStockIssued	44285000	usd
CY2024Q1	LUCD	Less Fair Value Related To Newly Issued Series B Preferred Stock Shares LessFairValueRelatedToNewlyIssuedSeriesBPreferredStockShares	12495000	shares
CY2024Q1	LUCD	Less Fair Value Related To Newly Issued Series B Preferred Stock LessFairValueRelatedToNewlyIssuedSeriesBPreferredStock	12495000	usd
CY2024Q1	LUCD	Less Carrying Value Related To Series And Series A1 Preferred Stock Exchanged For Series B Preferred Stock Shares LessCarryingValueRelatedToSeriesAndSeriesA1PreferredStockExchangedForSeriesBPreferredStockShares	24295000	shares
CY2024Q1	LUCD	Less Carrying Value Related To Series And Series A1 Preferred Stock Exchanged For Series B Preferred Stock LessCarryingValueRelatedToSeriesAndSeriesA1PreferredStockExchangedForSeriesBPreferredStock	24295000	usd
CY2024Q1	LUCD	Deemed Dividend Charged To Accumulated Deficit DeemedDividendChargedToAccumulatedDeficit	7495000	usd
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	46747062	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	42329864	shares
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-10612000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-16247000	usd
CY2024Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	7496000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-18108000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-16247000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	45014410	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	45014410	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40970504	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40970504	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.40
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.40
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.40
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.40
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	46217467	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	20620408	shares

Files In Submission

Name	View Source	Status
0001493152-24-018800-index-headers.html	Edgar Link	pending
0001493152-24-018800-index.html	Edgar Link	pending
0001493152-24-018800.txt	Edgar Link	pending
0001493152-24-018800-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
lucd-20240331.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
lucd-20240331_cal.xml	Edgar Link	unprocessable
lucd-20240331_pre.xml	Edgar Link	unprocessable
lucd-20240331_lab.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
lucd-20240331_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LUCD
Lucid Diagnostics Inc Stock $lucd

2024 Q2 Form 10-Q Financial Statement

#000149315224018800 Filed on May 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LUCD Lucid Diagnostics Inc Stock $lucd

2024 Q2 Form 10-Q Financial Statement

#000149315224018800 Filed on May 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LUCD
Lucid Diagnostics Inc Stock $lucd